Kymera Therapeutics, Inc. (KYMR) vs TG Therapeutics, Inc. (TGTX)
- Kymera Therapeutics, Inc. KYMR 104.78 −3.11%
- TG Therapeutics, Inc. TGTX 53.97 −3.63%
Kymera Therapeutics, Inc. and TG Therapeutics, Inc. are both Biotechnology companies. Kymera Therapeutics, Inc. and TG Therapeutics, Inc. are of similar size ($9.0B and $8.6B). Kymera Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; TG Therapeutics, Inc. trades at 17.8×. Kymera Therapeutics, Inc. grew revenue faster over the last twelve months: 134.8% against 76.1%. TG Therapeutics, Inc. has the higher net margin (55.2% vs −285.3%) and the higher return on invested capital (10.7% vs −26.7%). Across the 18 metrics below, TG Therapeutics, Inc. leads on 13 and Kymera Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | KYMR | TGTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 82.37% | 65.16% |
| Operating margin | (333.50%) | 17.05% | 0.00% |
| Net margin | (285.33%) | 55.22% | 0.00% |
| Free cash flow margin | (226.62%) | 2.17% | 0.00% |
| Return on equity | (24.15%) | 100.28% | (56.36%) |
| Return on assets | (21.58%) | 37.70% | (48.04%) |
| Return on invested capital | (26.72%) | 10.69% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack